Page last updated: 2024-08-21

glycyrrhizic acid and Bone Loss, Perimenopausal

glycyrrhizic acid has been researched along with Bone Loss, Perimenopausal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bao, YZ; Lv, XL; Tang, Y; Wang, JR1
Chen, X; Guo, S; Li, S; Liu, T; Ouyang, Z; Peng, D; Wu, Q; Yin, Z; Zhang, Q; Zhu, W1

Other Studies

2 other study(ies) available for glycyrrhizic acid and Bone Loss, Perimenopausal

ArticleYear
Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
    Climacteric : the journal of the International Menopause Society, 2021, Volume: 24, Issue:3

    Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Disease Models, Animal; Female; Glycyrrhizic Acid; Humans; Mice; Mice, Inbred C57BL; Monocytes; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; RAW 264.7 Cells; Signal Transduction

2021
Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
    European journal of pharmacology, 2019, Sep-15, Volume: 859

    Topics: Animals; Cell Differentiation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Glycyrrhizic Acid; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; RANK Ligand; RAW 264.7 Cells

2019
chemdatabank.com